Michael Arthur Bruckman
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$2.4MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 1, 2025 | NIH | SBIR Phase II SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate Bleeding in Thrombocytopenia | $50K | Haima Therapeutics, LLC |
| Jun 6, 2024 | NIH | SBIR Phase II SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate Bleeding in Thrombocytopenia | $113K | Haima Therapeutics, LLC |
| May 20, 2024 | NIH | SBIR Phase II SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate Bleeding in Thrombocytopenia | $972K | Haima Therapeutics, LLC |
| Jun 1, 2023 | NIH | SBIR Phase II SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate Bleeding in Thrombocytopenia | $994K | Haima Therapeutics, LLC |
| May 24, 2019 | NIH | SBIR Phase I SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate Bleeding in Thrombocytopenia | $300K | Haima Therapeutics, LLC |
Peer ranks
Federal funding#887
Awards as PI#470
Patents#505
Companies
- Haima Therapeutics, LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.